WATSON 607 (Labetalol 300 mg)
Pill imprint WATSON 607 has been identified as Labetalol hydrochloride 300 mg.
Labetalol is used in the treatment of hypertensive emergency; high blood pressure; pheochromocytoma; postural orthostatic tachycardia syndrome; mitral valve prolapse and belongs to the drug class non-cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Labetalol 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- WATSON 607
- 300 mg
- 11.00 mm
- Prescription only
- Drug Class:
- Non-cardioselective beta blockers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|68084-0457||Amerisource Health Services|
|60429-0279||Golden State Medical Supply (repackager)|
Note: Inactive ingredients may vary.
More about labetalol
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.